Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov:1143:61-82.
doi: 10.1196/annals.1443.011.

Basic and clinical immunology of Siglecs

Affiliations
Review

Basic and clinical immunology of Siglecs

Stephan von Gunten et al. Ann N Y Acad Sci. 2008 Nov.

Abstract

Siglecs are cell-surface proteins found primarily on hematopoietic cells. By definition, they are members of the immunoglobulin gene super-family and bind sialic acid. Most contain cytoplasmic tyrosine motifs implicated in cell signaling. This review will first summarize characteristics common and unique to Siglecs, followed by a discussion of each human Siglec in numerical order, mentioning in turn its closest murine ortholog or paralog. Each section will describe its pattern of cellular expression, latest known immune functions, ligands, and signaling pathways, with the focus being predominantly on CD33-related Siglecs. Potential clinical and therapeutic implications of each Siglec will also be covered.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Dr. Bochner is a co-author on existing and pending Siglec-8-related patents. If Siglec-8-related products are developed in the future, under a licensing agreement between Glaxo-SmithKline and the Johns Hopkins University, Dr. Bochner may be entitled to a share of royalties received by the University on the potential sales of such products. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies.

Figures

Figure 1
Figure 1
Nomenclature and key structural characteristics of human Siglecs. Although 15 are shown, Siglec-13 is present in nonhuman primates but not in man. V structures indicate the arginine-containing V-set domains with lectin activity; these are followed by C2-type Ig repeat domains. U-shaped structures for Siglec-XII indicate the mutated V-set domains missing arginine that have lost their lectin activity. Also shown is DAP12, illustrated as a shorter transmembrane structure co-associating with Siglec-13, Siglec-14, and Siglec-15. See key for symbols representing cytoplasmic signaling motifs.
Figure 2
Figure 2
Nomenclature and key structural characteristics of mouse Siglecs. V structures indicate the arginine-containing V-set domains with lectin activity; these are followed by C2-type Ig repeat domains. Also shown is DAP12, illustrated as a shorter transmembrane structure co-associating with Siglec-15 and Siglec-H. Whether Siglec-H, shown as having an arginine-containing V-set domains with lectin activity, can bind sialic acid ligands remains controversial (see text). Note that Siglecs-1–4 are conserved with humans, as is Siglec-15 (compare to Fig. 1). While not true orthologs, the closest functional paralog of Siglec-E is Siglec-9, while Siglec-F resembles Siglec-8 and Siglec-G resembles Siglec-10.
Figure 3
Figure 3
Relative affinities of Siglecs with selected sialoside sequences. A comparison of the sialoside specificities, obtained from glycan array analysis and competitive binding experiments, for several sialic acid–binding immunoglobulin-like lectins (Siglecs) against selected sialoside sequences found in mammalian glycoproteins and glycolipids,,, (see also the Functional Glycomics web site). Despite the general low affinity of Siglecs toward the common mammalian sialoside structures containing the N-acetylneuraminic acid (Neu5 Ac) α2–6 and α2–3 linkages, examination of the binding of each individual Siglec to a range of common sialoside structures shows that a unique sialoside specificity profile is characteristic of each Siglec. +++, strong binding; ++, moderate binding; +, low binding; ±, detectable binding; 0, no detectable binding; GlcNAc, N-acetylglucosamine; ND, not determined; Neu5 Gc, N-glycolylneuraminic acid. Legend and figure reproduced from Ref. with permission.

References

    1. Crocker PR, et al. Siglecs: a family sialic-acid binding lectins. Glycobiology. 1998;8:v–vi. - PubMed
    1. Varki A, Angata T. Siglecs – the major subfamily of I-type lectins. Glycobiology. 2006;16:1R–27R. - PubMed
    1. Brinkman-Van der Linden EC, et al. Human-specific expression of Siglec-6 in the placenta. Glycobiology. 2007;17:922–931. - PubMed
    1. Angata T, Varki NM, Varki A. A second uniquely human mutation affecting sialic acid biology. J Biol Chem. 2001;276:40282–40287. - PubMed
    1. Angata T, et al. Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. Proc Natl Acad Sci USA. 2004;101:13251–13256. - PMC - PubMed

Publication types

MeSH terms

Substances